The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, however its legacy within the broader market now raises questions about future yields . Alternative versions are eroding market share, prompting anxieties that betting on companies closely tied to Viagra's once-dominant influence could be a problematic m